These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 33941556

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prognostic significance of immune checkpoints in the tumour-stromal microenvironment of sebaceous gland carcinoma.
    Singh L, Singh MK, Rizvi MA, Pushker N, Bakhshi S, Sen S, Kashyap S.
    Br J Ophthalmol; 2021 Jan; 105(1):48-56. PubMed ID: 32277010
    [Abstract] [Full Text] [Related]

  • 9. PD1 (CD279) and PD-L1 (CD274, B7H1) expression in primary central nervous system lymphomas (PCNSL).
    Berghoff AS, Ricken G, Widhalm G, Rajky O, Hainfellner JA, Birner P, Raderer M, Preusser M.
    Clin Neuropathol; 2014 Jan; 33(1):42-9. PubMed ID: 24359606
    [Abstract] [Full Text] [Related]

  • 10. The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1.
    Sugita Y, Furuta T, Ohshima K, Komaki S, Miyoshi J, Morioka M, Abe H, Nozawa T, Fujii Y, Takahashi H, Kakita A.
    Neuropathology; 2018 Apr; 38(2):125-134. PubMed ID: 29067721
    [Abstract] [Full Text] [Related]

  • 11. PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia/lymphoma.
    Miyoshi H, Kiyasu J, Kato T, Yoshida N, Shimono J, Yokoyama S, Taniguchi H, Sasaki Y, Kurita D, Kawamoto K, Kato K, Imaizumi Y, Seto M, Ohshima K.
    Blood; 2016 Sep 08; 128(10):1374-81. PubMed ID: 27418641
    [Abstract] [Full Text] [Related]

  • 12. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
    Qian J, Wang C, Wang B, Yang J, Wang Y, Luo F, Xu J, Zhao C, Liu R, Chu Y.
    J Neuroinflammation; 2018 Oct 17; 15(1):290. PubMed ID: 30333036
    [Abstract] [Full Text] [Related]

  • 13. Expression of programmed death ligand 1 is associated with poor prognosis in myeloid sarcoma patients.
    Kawamoto K, Miyoshi H, Suzuki T, Kiyasu J, Yokoyama S, Sasaki Y, Sone H, Seto M, Takizawa J, Ohshima K.
    Hematol Oncol; 2018 Aug 17; 36(3):591-599. PubMed ID: 29602174
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma.
    Guo XJ, Lu JC, Zeng HY, Zhou R, Sun QM, Yang GH, Pei YZ, Meng XL, Shen YH, Zhang PF, Cai JB, Huang PX, Ke AW, Shi YH, Zhou J, Fan J, Chen Y, Yang LX, Shi GM, Huang XY.
    Front Immunol; 2021 Aug 17; 12():705378. PubMed ID: 34526987
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholangiocarcinoma cells.
    Suriyo T, Fuangthong M, Artpradit C, Ungtrakul T, Sricharunrat T, Taha F, Satayavivad J.
    Eur J Pharmacol; 2021 Apr 15; 897():173960. PubMed ID: 33617828
    [Abstract] [Full Text] [Related]

  • 17. APE1 facilitates PD-L1-mediated progression of laryngeal and hypopharyngeal squamous cell carcinoma.
    Wang J, Lun L, Jiang X, Wang Y, Li X, Du G, Wang J.
    Int Immunopharmacol; 2021 Aug 15; 97():107675. PubMed ID: 33964809
    [Abstract] [Full Text] [Related]

  • 18. Prognostic implications of the tumor immune microenvironment and immune checkpoint pathway in primary central nervous system diffuse large B-cell lymphoma in the North Indian population.
    Parkhi M, Chatterjee D, Bal A, Vias P, Yadav BS, Prakash G, Gupta SK, Radotra BD.
    APMIS; 2022 Feb 15; 130(2):82-94. PubMed ID: 34862664
    [Abstract] [Full Text] [Related]

  • 19. The prognostic impact of programmed cell death ligand 1 and human leukocyte antigen class I in pancreatic cancer.
    Imai D, Yoshizumi T, Okano S, Uchiyama H, Ikegami T, Harimoto N, Itoh S, Soejima Y, Aishima S, Oda Y, Maehara Y.
    Cancer Med; 2017 Jul 15; 6(7):1614-1626. PubMed ID: 28602029
    [Abstract] [Full Text] [Related]

  • 20. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
    Li Y, Liang L, Dai W, Cai G, Xu Y, Li X, Li Q, Cai S.
    Mol Cancer; 2016 Aug 24; 15(1):55. PubMed ID: 27552968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.